{
    "Trade/Device Name(s)": [
        "BD Veritor System Flu A+B Assay",
        "BD Veritor System for Rapid Detection of Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K132693",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132259"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "October 2, 2013",
    "Summary Letter Received Date": "September 4, 2013",
    "Submission Date": "August 23, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash",
        "Nasopharyngeal aspirate",
        "Nasopharyngeal swab in transport media"
    ],
    "Specimen Container(s)": [
        "Transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay",
        "Colloidal-gold particle detection"
    ],
    "Methodologies": [
        "Qualitative immunoassay",
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System Flu A+B rapid chromatographic immunoassay for qualitative detection of influenza A and B viral antigens",
    "Indications for Use Summary": "Aid in diagnosis of influenza A and B viral infections in symptomatic patients using nasopharyngeal specimens, distinguishing influenza A from B antigens; negative results should be confirmed by viral culture or FDA-cleared molecular assay",
    "fda_folder": "Microbiology"
}